Pyridostigmine Bromide
NDC 64980-220, Pyridostigmine Bromide, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-220
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205464
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE180 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-220-03 | 64980022003 | 30 TABLET in 1 BOTTLE (64980-220-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f7a75639-a23a-4847-a962-c091c61947f0NADAC price for package 64980022003
GET /v1/drugs/nadac/64980022003
Use it
Look up 64980-220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.